C. Robert Horsburgh, MD

Professor, Epidemiology
C. Horsburgh
(617) 638-7775rhorsbu@bu.edu
Talbot – T326E
View full profile at BUMC


Dr. Horsburgh has 30 years of experience in public health and medicine. He currently holds faculty positions in the Department of Biostatistics and the Department of Medicine. Dr. Horsburgh teaches courses in the Epidemiology of AIDS and the Epidemiology of Tuberculosis. He has focused his research on tuberculosis, nontuberculous mycobacterial infections and opportunistic infections in AIDS and has served as the National Steering Committee Co-Chairman of the Tuberculosis Trials Consortium and the Tuberculosis Epidemiologic Studies Consortium. He is currently the Chairman of the Steering Committee of RESIST-TB, an international organization dedicated to improving MDR-TB treatment through Clinical Trials.

Other Positions:

  • Professor of Epidemiology, Epidemiology, Boston University School of Public Health
  • Professor, Infectious Diseases, Medicine, Boston University School of Medicine
  • Professor, Biostatistics, Boston University School of Public Health
  • Boston Medical Center


  • Case Western Reserve University, MD
  • Yale University, MUS
  • Princeton University, AB

Classes Taught

  • SPHEP764
  • SPHEP784
  • SPHEP911
  • SPHEP911


  • Published on 8/19/2015

    Hermans S, Horsburgh CR, Wood R. A Century of Tuberculosis Epidemiology in the Northern and Southern Hemisphere: The Differential Impact of Control Interventions. PLoS One. 2015; 10(8):e0135179.

    Read at: PubMed
  • Published on 8/15/2015

    O'Donnell MR, Pillay M, Pillay M, Werner L, Master I, Wolf A, Mathema B, Coovadia YM, Mlisana K, Horsburgh CR, Padayatchi N. Primary Capreomycin Resistance Is Common and Associated With Early Mortality in Patients With Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr. 2015 Aug 15; 69(5):536-43.

    Read at: PubMed
  • Published on 7/17/2015

    Simonsen DF, Søgaard M, Bozi I, Horsburgh CR, Thomsen RW. Risk factors for postoperative pneumonia after lung cancer surgery and impact of pneumonia on survival. Respir Med. 2015 Oct; 109(10):1340-6.

    Read at: PubMed
  • Published on 6/9/2015

    Ristola M, Arbeit RD, von Reyn CF, Horsburgh CR. Isolation of Mycobacterium avium from Potable Water in Homes and Institutions of Patients with HIV Infection in Finland and the United States. Biomed Res Int. 2015; 2015:713845.

    Read at: PubMed
  • Published on 2/28/2015

    Anderson JP, Horsburgh CR, Williams PL, Tchetgen Tchetgen EJ, Nunes D, Cotton D, Seage GR. CD4 recovery on antiretroviral therapy is associated with decreased progression to liver disease among hepatitis C virus-infected injecting drug users. Open Forum Infect Dis. 2015 Jan; 2(1):ofv019.

    Read at: PubMed
  • Published on 2/15/2015

    Horsburgh CR. Overestimation of coprevalent and underestimation of incident tuberculosis in close contacts. Am J Respir Crit Care Med. 2015 Feb 15; 191(4):486-7.

    Read at: PubMed
  • Published on 7/23/2014

    Daley CL, Horsburgh CR. Editorial commentary: Treatment for multidrug-resistant tuberculosis: it''s worse than we thought! Clin Infect Dis. 2014 Oct 15; 59(8):1064-5.

    Read at: PubMed
  • Published on 5/14/2014

    Assoumou SA, Huang W, Horsburgh CR, Drainoni ML, Linas BP. Relationship between hepatitis C clinical testing site and linkage to care. Open Forum Infect Dis. 2014 Mar; 1(1):ofu009.

    Read at: PubMed
  • Published on 3/21/2014

    Hochberg NS, Kubiak RW, Tibbs A, Elder H, Sharnprapai S, Etkind S, Horsburgh CR. Effectiveness of reporting on latent tuberculous infection in Massachusetts, 2006-2008. Public Health Action. 2014 Mar 21; 4(1):53-5.

    Read at: PubMed
  • Published on 3/1/2014

    Horsburgh CR. Tuberculosis. Eur Respir Rev. 2014 Mar 1; 23(131):36-9.

    Read at: PubMed

View 136 more publications:View full profile at BUMC